» Articles » PMID: 3549716

Biosynthesis of Lipid A Precursors in Escherichia Coli. A Cytoplasmic Acyltransferase That Converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1987 Apr 15
PMID 3549716
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Preliminary studies from our laboratory have suggested the existence of a novel set of fatty acyltransferases in extracts of Escherichia coli that attach two R-3-hydroxymyristoyl moieties to UDP-GlcNAc (Anderson, M.S., Bulawa, C.E., and Raetz, C.R.H. (1985) J. Biol. Chem. 260, 15536-15541). The resulting "glucosamine-derived" phospholipids appear to be crucial precursors for the biosynthesis of the lipid A component of lipopolysaccharide. We now describe an assay and a 1000-fold purification of the first enzyme in this pathway, which catalyzes the reaction: UDP-GlcNAc + R-3-hydroxymyristoyl-acyl carrier protein----UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc + acyl carrier protein. The covalent structure of the monoacylated UDP-GlcNAc product was established by fast atom bombardment mass spectrometry and 1H-NMR spectroscopy. The UDP-GlcNAc acyltransferase has a strict requirement for R-3-hydroxymyristoyl-acyl carrier protein, since R-3-hydroxymyristoyl coenzyme A and myristoyl-acyl carrier protein are not substrates. Of various NDP-GlcNAc preparations examined, only the uridine and thymidine derivatives were utilized to a significant extent. When the product of the reaction (UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc) was isolated and reincubated with crude E. coli extracts, it was rapidly converted to more hydrophobic products in the presence of R-3-hydroxymyristoyl-acyl carrier protein. We propose that the addition of an R-3-hydroxymyristoyl residue to the 3 position of the GlcNAc moiety of UDP-GlcNAc is the first committed step in lipid A biosynthesis and that UDP-GlcNAc is situated at a biosynthetic branchpoint in E. coli leading either to lipid A or to peptidoglycan.

Citing Articles

Correlation between intestinal microbiota and urolithin metabolism in a human walnut dietary intervention.

Liu H, Birk J, Provatas A, Vaziri H, Fan N, Rosenberg D BMC Microbiol. 2024; 24(1):476.

PMID: 39548408 PMC: 11566485. DOI: 10.1186/s12866-024-03626-5.


Maintenance of bacterial outer membrane lipid asymmetry: insight into MlaA.

Kaur M, Mingeot-Leclercq M BMC Microbiol. 2024; 24(1):186.

PMID: 38802775 PMC: 11131202. DOI: 10.1186/s12866-023-03138-8.


Suppressors of Mutation Identify New Regulators of LpxC, Which Mediates the First Committed Step in Lipopolysaccharide Biosynthesis.

Maniyeri A, Wieczorek A, Ayyolath A, Sugalska W, Klein G, Raina S Int J Mol Sci. 2023; 24(20).

PMID: 37894855 PMC: 10607373. DOI: 10.3390/ijms242015174.


A role for the Gram-negative outer membrane in bacterial shape determination.

Fivenson E, Rohs P, Vettiger A, Sardis M, Torres G, Forchoh A Proc Natl Acad Sci U S A. 2023; 120(35):e2301987120.

PMID: 37607228 PMC: 10469335. DOI: 10.1073/pnas.2301987120.


Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope.

Kaderabkova N, Mahmood A, Furniss R, Mavridou D Adv Microb Physiol. 2023; 83:221-307.

PMID: 37507160 PMC: 10517717. DOI: 10.1016/bs.ampbs.2023.05.003.